BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37367817)

  • 1. Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma.
    Wang B; Zhou Y; Zhang P; Li J; Lu X
    Am J Chin Med; 2023; 51(5):1293-1308. PubMed ID: 37367817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
    Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
    Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
    Bi W; Yang M; Xing P; Huang T
    Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
    Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
    Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
    Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Wang H; Zhang P
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandrin B suppresses osteosarcoma lung metastasis
    Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxypeptidase E-ΔN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-β-catenin pathway.
    Fan S; Gao X; Chen P; Li X
    Biochem Cell Biol; 2019 Aug; 97(4):446-453. PubMed ID: 30508384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
    Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of HOXB8 inhibits tumor growth and metastasis by the inactivation of Wnt/β-catenin signaling pathway in osteosarcoma.
    Guo J; Zhang T; Dou D
    Eur J Pharmacol; 2019 Jul; 854():22-27. PubMed ID: 30954562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.
    Yang S; Zhou P; Zhang L; Xie X; Zhang Y; Bo K; Xue J; Zhang W; Liao F; Xu P; Hu Y; Yan R; Liu D; Chang J; Zhou K
    Cancer Biol Ther; 2023 Dec; 24(1):2230641. PubMed ID: 37405957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA GHET1 promotes osteosarcoma development and progression via Wnt/β‑catenin signaling pathway.
    Chen X; Zhao W; Fan W
    Oncol Rep; 2020 Jul; 44(1):349-359. PubMed ID: 32319657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
    Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
    Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
    Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.